Application 217126
- Type
- ANDA
- Sponsor
- COSETTE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUCRALFATE | SUCRALFATE | SUSPENSION;ORAL | 1GM/10ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217126-001 | SUCRALFATE | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217126-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217126-001 | SUCRALFATE | 1GM/10ML | SUSPENSION / ORAL | AB | 2024-11-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A217126-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217126-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217126-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217126-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217126-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217126-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217126-001 | AB | 1 | 2680178bc6a6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217126-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | Safecor Health, LLC | 526f6ebc-557c-4c53-8118-1907baa0820a | 2026-07-16 | Warnings, Adverse reactions | 217126 ANDA217126 |
| Sucralfate | SUCRALFATE | Cosette Pharmaceuticals, Inc. | 3054ce94-78a2-4da4-8b14-95311b412ab2 | 2024-11-25 | Warnings, Adverse reactions | 217126 ANDA217126 |